Qi Tienan, Liu Hanhan, Frühn Layla, Löw Katrin, Cursiefen Claus, Prokosch Verena
Zentrum für Augenheilkunde, Medizinische Fakultät, Universität Köln, Deutschland.
Klin Monbl Augenheilkd. 2025 Jul;242(7):712-717. doi: 10.1055/a-2617-1575. Epub 2025 Jul 24.
Glaucoma is one of the leading causes of irreversible blindness worldwide and is often referred to as the "silent thief of sight", because it often progresses without noticeable symptoms until significant vision loss occurs. With an estimated 76 million patients affected in 2020 and a forecast of over 111 million by 2040, the global situation requires urgent attention. Vision loss caused by glaucoma is irreversible but largely preventable, highlighting the importance of early detection and treatment. Diagnosis presents significant challenges, particularly due to the asymptomatic nature of the disease and age-related risk factors. Inequalities in care and access to appropriate treatments are other barriers leading to delayed diagnoses. Early diagnosis and interventions are critical to slow disease progression, protect remaining vision and improve the quality of life of those affected. These measures are particularly important to minimise the psychological impact and impairment in daily activities. The use of innovative technologies and targeted interventions could help improve the early detection and treatment of glaucoma and thus reduce the risk of irreversible vision loss.
青光眼是全球不可逆性失明的主要原因之一,常被称为“视力的无声窃贼”,因为它通常在没有明显症状的情况下进展,直到出现严重视力丧失才被发现。2020年估计有7600万患者受影响,预计到2040年将超过1.11亿,全球形势亟需关注。青光眼导致的视力丧失是不可逆的,但在很大程度上是可预防的,这凸显了早期发现和治疗的重要性。诊断面临重大挑战,特别是由于该疾病无症状的性质以及与年龄相关的风险因素。医疗保健方面的不平等以及获得适当治疗的机会是导致诊断延迟的其他障碍。早期诊断和干预对于减缓疾病进展、保护剩余视力以及改善患者生活质量至关重要。这些措施对于将心理影响和日常活动中的损伤降至最低尤为重要。使用创新技术和有针对性的干预措施有助于改善青光眼的早期发现和治疗,从而降低不可逆视力丧失的风险。